Related Experiment Videos
Generation of insulin-producing cells from stem cells
Bernat Soria1, Enrique Roche, Juan A Reig
1Institute of Bioengineering, University Miguel Hernandez, San Juan, 03550 Alicante, Spain.
Novartis Foundation Symposium
|July 30, 2005
Summary
Stem cell therapy offers a promising alternative for diabetes treatment. Researchers successfully generated insulin-secreting cells from embryonic stem cells, normalizing blood glucose in diabetic animal models.
Area of Science:
- Stem Cell Biology
- Endocrinology
- Regenerative Medicine
Background:
- Islet transplantation for diabetes is limited by donor scarcity.
- Stem cells offer a renewable source for cell-based therapies.
- Embryonic stem cells can differentiate into various cell types, including insulin-producing cells.
Purpose of the Study:
- To develop a method for generating functional insulin-secreting cells from embryonic stem cells.
- To evaluate the therapeutic potential of these derived cells in a diabetic animal model.
Main Methods:
- Utilized a combination of differentiation methods and a 'cell trapping' system for stem cell differentiation.
- Engineered a construct for neomycin selection driven by beta cell gene regulatory regions (insulin, Nkx6.1).
- Transplanted derived insulin-secreting cells into streptozotocin-induced diabetic mice.
Main Results:
- Transplanted cells corrected hyperglycemia within one week and restored body weight.
- Graft removal reversed the therapeutic effect, confirming graft function.
- Glucose tolerance tests and post-meal blood glucose levels normalized in transplanted animals.
Conclusions:
- This approach successfully generated functional insulin-secreting cells from embryonic stem cells.
- Stem cell-derived cells demonstrate potential for treating type 1 and type 2 diabetes.
- This method offers a novel strategy for cell-based tissue transplantation in diabetes therapy.